Yet, KRAS/TP53/CIC-mutant LUADs display multiple differentially expressed genes when compared with KRAS/TP53-mutant tumors, although this, as well as the lack of allelic imbalances, needs to be confirmed in additional tumor samples (Appendix Fig. S1C). The gene discussed is KRAS; the disease is neoplasm.